Singapore, July 3 -- Attoplex Inc., a South Korea-based startup specialising in in vitro diagnostic (IVD) medical devices, has signed a Memorandum of Understanding (MoU) with ProfessorMinsu Kim'sresearch team from the School of Computing atKorea Advanced Institute of Science and Technology (KAIST) for the joint development of artificial intelligence (AI)-based diagnostic reagents for high-risk pathogens."

The MoU aims to develop diagnostic reagents that maintain high sensitivity and specificity, even for rapidly mutating pathogens such as RNA viruses. The collaboration will focus on commercialising "VPrimer", an automated primer-probe design algorithm developed by Professor Kim's team.

VPrimer is an algorithm that analyses thousands of ...